Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy

Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy

LOS ANGELES--(BUSINESS WIRE)--Jun 17, 2025-

Hairmax Partners with Truemed to Accept FSA/HSA Payments on FDA-Cleared Laser Hair Growth Devices

Medical-Grade Hair Growth Devices Now Eligible for Pre-Tax Funds

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

PP405 targets the primary biological pathway that controls the natural hair growth cycle, separating it from existing therapies.

13 Hair Serums For A Thicker Mane

From stress to hormones to genetics, hair loss is an increasingly common phenomena.